Companies: 10,795·Total market cap: $144.5T
Lite Strategy, Inc.

Lite Strategy, Inc.

LITSNASDAQFinancial Services● Active
$0.75
+$0.01(+0.81%)
Market Cap$25685623
P/E Ratio
52W High$9
52W Low$0.7

Lite Strategy, Inc. (LITS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

lits · pe ratio · data through Jun 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Lite Strategy, Inc. (LITS) measures how much investors pay for each dollar of the company's trailing earnings. LITS's current PE ratio of N/A is calculated by dividing its stock price of $0.75 by its TTM earnings per share of -$9.13.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30

Forward P/E
N/A
FY2026 est. EPS $-3.71
Based on 1 analyst
EPS (TTM)
-$9.13
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lite Strategy, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2021 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 1.7x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Asset Management - Cryptocurrency · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Lite Strategy, Inc.
Lite Strategy, Inc.You
LITS
$26MN/A-$9.13
Adicet Bio, Inc.
Adicet Bio, Inc.
ACET
$67MN/A-$16.95
Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc. Common Stock
ACRV
$44MN/A-$2.02
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc.
HOWL
$19MN/A-$1.32
Immunic, Inc.
Immunic, Inc.
IMUX
$119MN/A-$6.24
IO Biotech, Inc.
IO Biotech, Inc.
IOBT
$1MN/A-$1.45
Nutriband Inc.
Nutriband Inc.
NTRB
$43MN/A-$0.71

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-06-30Latest
FY2025
$-2.39
2024-06-30
FY2024
1.70x$2.67
2023-06-30
FY2023
$-4.78
2022-06-30
FY2022
$-8.75
2021-06-30
FY2021
$-7.34

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Lite Strategy, Inc. (LITS) measures how much investors pay for each dollar of the company's trailing earnings. LITS's current PE ratio of N/A is calculated by dividing its stock price of $0.75 by its TTM earnings per share of -$9.13.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.75 ÷ -$9.13 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

LITS pe ratio · 6 questions

LITS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.75 and TTM EPS of -$9.13. Data sourced from Financial Modeling Prep via LITS's SEC 10-K and 10-Q filings.

LITS PE ratioWhat is LITS PE ratioCurrent PE ratio of LITSLITS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lite Strategy, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09